Citius Pharmaceuticals Inc (CTXR): Next-Year EPS Estimate 56.68%
As of 2026-06-11, Citius Pharmaceuticals Inc (CTXR) has a next-year EPS growth estimate of 56.68%.
On 2026-05-31, analyst consensus for CTXR's next-year EPS growth shifted from 1042.86% to 56.68% — a negative change of 986.18 percentage points. The revised estimate has been sustained across 10 subsequent trading sessions. Current-year growth is projected at 44.67%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 56.68%
- EPS growth this year
- 44.67%
- EPS next quarter (est)
- -$0.36
- Last price
- $0.57
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 56.68% | 44.67% | -$0.36 | $0.57 |
| 2026-06-10 | 56.68% | 44.67% | -$0.36 | $0.55 |
| 2026-06-09 | 56.68% | 44.67% | -$0.36 | $0.56 |
| 2026-06-08 | 56.68% | 44.67% | -$0.36 | $0.59 |
| 2026-06-07 | 56.68% | 44.67% | -$0.36 | $0.56 |
| 2026-06-04 | 56.68% | 44.67% | -$0.36 | $0.59 |
| 2026-06-03 | 56.68% | 44.67% | -$0.36 | $0.58 |
| 2026-06-02 | 56.68% | 44.67% | -$0.36 | $0.60 |
| 2026-06-01 | 56.68% | 44.67% | -$0.36 | $0.63 |
| 2026-05-31 | 56.68% | 44.67% | -$0.36 | $0.65 |
| 2026-05-28 | 1042.86% | 96.89% | $0.03 | $0.65 |
| 2026-05-27 | 1042.86% | 96.89% | $0.03 | $0.69 |
| 2026-05-26 | 1042.86% | 96.89% | $0.03 | $0.70 |
| 2026-05-25 | 1042.86% | 96.89% | $0.03 | $0.70 |
| 2026-05-24 | 1042.86% | 96.89% | $0.03 | $0.70 |
| 2026-05-21 | 1042.86% | 96.89% | $0.03 | $0.67 |
| 2026-05-20 | 1042.86% | 96.89% | $0.03 | $0.58 |
| 2026-05-19 | 1042.86% | 96.89% | $0.03 | $0.55 |
| 2026-05-18 | 1042.86% | 96.89% | -$0.28 | $0.53 |
| 2026-05-17 | 68.07% | 149.11% | $0.39 | $0.70 |
| 2026-05-14 | 68.07% | 149.11% | $0.39 | $0.72 |
| 2026-05-13 | 68.07% | 149.11% | $0.39 | $0.65 |
| 2026-05-12 | 68.07% | 149.11% | $0.39 | $0.61 |
| 2026-05-11 | 68.07% | 149.11% | $0.39 | $0.64 |
| 2026-05-10 | 68.07% | 149.11% | $0.39 | $0.64 |
| 2026-05-07 | 68.07% | 149.11% | $0.39 | $0.65 |
| 2026-05-06 | 68.07% | 149.11% | $0.39 | $0.67 |
| 2026-05-05 | 68.07% | 149.11% | $0.39 | $0.69 |
| 2026-05-04 | 68.07% | 149.11% | $0.39 | $0.71 |
| 2026-05-03 | 68.07% | 149.11% | $0.39 | $0.70 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Citius Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Citius Pharmaceuticals Inc (CTXR) has a next-year EPS growth estimate of 56.68%, based on analyst consensus.
When was the latest EPS estimate revision for CTXR?▾
The most recent revision occurred on 2026-05-31, when analysts adjusted the next-year EPS growth estimate from 1042.86% to 56.68%.
What sector and industry does Citius Pharmaceuticals Inc belong to?▾
Citius Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. CTXR appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Citius Pharmaceuticals Inc (CTXR) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports